Position in GILD
as of Jun 30, 2026
· filed Aug 17, 2026
Position Value
$8,696,487
-$929,241 QoQ
Shares Held
68,834
-0.3% QoQ
Ownership
0.006%
of shares outstanding
% of Portfolio
0.82%
of 13F equity value
Holder Rank
#455
of 2,266 holders
Holding Since
Mar 2025
6 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Coastal Bridge Advisors, LLC holds $56,459,277 across 9 Drug Manufacturers - General names. GILD ranks #3 (15.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
62,933 | $15,983,094 | |
| 2 | ABBV |
AbbVie Inc.
|
61,434 | $15,459,251 | |
| 3 | GILD |
Gilead Sciences, Inc.
This page
|
68,834 | $8,696,487 | |
| 4 | AMGN |
Amgen Inc
|
14,287 | $5,173,608 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
56,768 | $3,270,972 | |
| 6 | LLY |
ELI LILLY & Co
|
2,467 | $2,958,994 | |
| 7 | MRK |
Merck & Co., Inc.
|
21,141 | $2,716,618 | |
| 8 | PFE |
Pfizer Inc
|
78,442 | $1,888,883 |
All Filings in GILD
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $8,696,487 | 68,834 | Shares | Sole | 2026-08-17 | |
| 2026-03-31 | $9,625,728 | 69,066 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $8,544,667 | 69,616 | Shares | Sole | 2026-02-18 | |
| 2025-09-30 | $4,719,720 | 42,520 | Shares | Sole | 2025-11-03 | |
| 2025-06-30 | $4,724,503 | 42,613 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $4,773,778 | 42,604 | Shares | Sole | 2025-08-25 | |
| No filing history on record for this holder in this stock. | ||||||